Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Pmv Pharmaceuticals Inc (PMVP)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Pmv Pharma's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.750 +0.040    +2.34%
27/04 - Closed. Currency in USD ( Disclaimer )
After Hours
1.750
0.000
0.000%
6:20:00 - Real-time Data
  • Volume: 334,405
  • Bid/Ask: 1.700 / 1.770
  • Day's Range: 1.690 - 1.765
Type:  Equity
Market:  United States
Pmv Pharma 1.750 +0.040 +2.34%

Pmv Pharmaceuticals Inc Company Profile

 
Get an in-depth profile of Pmv Pharmaceuticals Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

63

Equity Type

ORD

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. It’s lead product candidate is PC14586, a small molecule that corrects mutant p53 protein containing the Y220C mutation and restores wild-type p53 function. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is based in Princeton, New Jersey.

Contact Information

Address 1 Research Way
Princeton, 08540
United States
Phone 609 642 6670
Fax -

Top Executives

Name Age Since Title
Scott W. Lowe - - Chairman of Scientific Advisory Board
David H. Mack 62 2013 Co-Founder, CEO, President & Director
Arnold J. Levine 84 2013 Co-Founder, Director & Member of Scientific Advisory Board
Frank P. McCormick 74 - Member of Scientific Advisory Board
Karen H. Vousden 65 - Member of Scientific Advisory Board
Charles M. Baum 66 2021 Independent Director
Michael E. Jung - - Member of Scientific Advisory Board
Richard A. Heyman 67 2020 Independent Chairman of the Board of Directors & Member of Scientific Advisory Board
Charles L. Sawyers 65 - Member of scientific Advisory Board
Kirsten Flowers 49 2022 Independent Director
Carol G. Gallagher 59 2022 Independent Director
Guillermina Lozano - 2021 Member of Scientific Advisory Board
Laurie D. Stelzer 56 2020 Independent Director
Thomas E. Shenk 77 2013 Co-Founder & Member of Scientific Advisory Board
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

PMVP Comments

Write your thoughts about Pmv Pharmaceuticals Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email